Member Info for violindog

12000 rounding up...

Far too short to spend time bickering ... enjoy the slight rise in share price and the sun. In two generations all of us certainly will be dead and most totally forgotten, as if you never had lived in the first place. So be kind to others.

Hi C7, I hope all is going well for you . It's a shame we drifted down from the 20/21 mark afew months ago, I never really understood why that happened. Yes , it would be great to achieve 17 p post a bumper RNS , just a shame the current sp is at such a low base. Anyway, we are where we are and it's no good thinking about the past.
Covidity news must be around the corner and I keep thinking about the "moditope lady" and how she is. I wonder when she will have her next scan...I pray for her and her family that it's positive news and as a SCLP investor obviously there's the financial implications as well. Whatever we as shareholders may gain you can't put a price on life or quality of life.

Roses, sorry, didn't notice your comment at the end re news incoming . Hope it is ..

Hi Roses, what's your take on this ..thanks

Clearnerworld...the Wosley in London? Looks lovely..count me in ! A pound a share this year would be amazing ...and now possible I feel !

I just feel a bid for SCLP is on the way . My take from the RNSs and the Covidity info from the protocol change: Covidity is working, Scib is working and we have Modi in trial. Along with the Mabs a cash rich pharma must be sorely tempted to go in for at least £1....starting bid : )) and see what Redmile say.

Just bought another 25000 at 13:99

Roses.....Sclp currently down 0.95%....incredible.

https://www.dailymail.co.uk/money/markets/article-10912283/MARKET-REPORT-Mining-shares-mayhem-digs-hole-blue-chips.html?ito=1490&utm_medium=referral&ns_mchannel=rss&utm_source=upday&ns_campaign=1490

Chester, indeed re your last post.... but also congratulations to us long term shareholders who have helped fund Scancell over many years to get the company and Moditope to this stage.
Very pleased with todays news.

Kolar, the cavity left behind won't be an issue. Tumors, non cancer growths, fatty tissue etc ... some quite massive.... are removed from all parts of the body evey day by the NHS . It has absolutely no consequence. The cavity may initially be filled by fluid but the body adapts as long as no nerves or major blood vessels are damaged or ruptured during surgery.
I stand to be corrected but that's my experience. Cavities are never filled by foreign objects due to infection. Occasionally a swab may be left insitu to stop bleeding or the swab may be soaked in antibiotics but they are always removed ASAP.

Despite my moans..
Moditope WILLtrial this year in prestigious hospitals and hopefully first pt dosed this month.
Covidity MUST have passed initial safety goals an be effective or why extend the trial in SA .
SCLPs pipeline is strong with more staff being employed.
Cancer immunotherapy is getting more and more press coverage with some amazing results.
Covid varients WILL evolve and a universal vaccine is the holy grail.
Billion dollar deals are being made in the USA for monoclonal antibodies. Scancell have collaborative "deals " but we don't know who with.
Redmile have deep pockets and experience in bio tech investing. Vulps ..the same.
Redmile can't buy any more shares as it would take them over 30 % .
So... lots of positives to counter balance a currently miserable share price. My investment in SCLP has been like a marathon...recently I "hit the wall" and I have been feeling a bit negative. Over that now having stepped away and looked at the fundamentals once again. Continuing the marathon analogy...I hope we are on the last few laps.

Chester, good points re the radiotherapy.. that had not crossed my mind. I'm just fed up waiting .

BO, but if shareholders were kept informed the speculation would end ? . Updates can only help confidence. The share price has floundered for years , along with timelines...so perhaps updates may even help.

Morning Yard, I agree... and now Sclp have Redmile and Vulps holding the purse strings they have no need for loyal shareholders that propped Sclp up through all the fundraising years.
It's one thing getting an impressive increase in trial centers but it's almost six months since LD indicated first patient dosed for Modi1. Are Sclp waiting for all these centers to be trained up ?
I can only think this is the reason. If not then why hasn't it started ?

AB, morning. Yes, perhaps leak was the wrong word to use. Either way... I see the information gleaned from the new protocol as hugely price positive , whether SCLP issue an RNS or they don't. The first hurdle has safely passed where i am sure many have failed.

You would expect/hope that having a "leak" Covidity is going OK in SA would raise the share price.

Wonder if SCLP will RNS any of this ?

Lofts...agree. Its not as if SCLP hasn't presented at major conferences etc..and these mega pharmaceutical companies must actively scout for potential targets. SCLP has an amazing pipeline of advanced products.
SCLP s market capital sits at sub 100m : why Redmile haven't been offered x amount for their holding ..it beggers belief. Once upon a time I wanted maximum value from SCLP having funded them over many years, but this has turned into a decade plus. Now , I would settle for £1 to be honest. With luck this may be what Redmile have been offered and they asked for more : ))